Live Signals
Signals ScoreSignals Score (0–100) blends the three technical signals — MA, RSI and MACD — where BUY = 100, HOLD/NEUTRAL = 50, SELL = 0.
Each signal is weighted by its own historical BUY hit-rate for this ticker (a signal that has been right more often counts for more). Hit-rates from only a handful of past signals are pulled toward equal weight, so a small, noisy sample can't swing the score.
Synthesis rank #134 / 155
(15.90)
(15.90)
(0.00)
2 of 3 frames agree
Sessions where price opened above the prior high or below the prior low
| Date | Type | Gap % | Prev Close | Open | Filled? |
|---|---|---|---|---|---|
| 2026-11-06 | Gap Down | -2.46% | $468.52 | $457.00 | Filled |
| 2026-11-04 | Gap Up | +4.14% | $440.75 | $458.99 | Open |
| 2026-10-30 | Gap Up | +1.08% | $448.76 | $453.60 | Filled |
| 2026-10-28 | Gap Down | -1.00% | $445.88 | $441.43 | Filled |
| 2026-10-21 | Gap Down | -8.11% | $438.00 | $402.50 | Filled |
| 2026-10-13 | Gap Up |
Candlestick patterns identified in recent price action
Doji
2026-11-13
Open and close nearly equal — market indecision. Most significant at swing highs/lows; often precedes a reversal or consolidation.
Support
Resistance
Stockasthics is an educational tool only. Nothing on this page constitutes financial advice. All signals, scores, and data are for informational and learning purposes only.
weekly
Signals from weekly candles smooth out daily noise and reveal the true intermediate trend. More reliable for direction. A BUY on the weekly carries more conviction than a daily BUY alone.
| +0.55% |
| $427.64 |
| $430.00 |
| Filled |
| 2026-10-05 | Gap Down | -0.56% | $391.95 | $389.76 | Filled |
| 2026-09-14 | Gap Up | +1.48% | $369.15 | $374.60 | Filled |
ISRG: -9.3% vs SPY: -6.7% → RS: -2.6% Relative Strength = stock return minus index return over the same window. Positive = outperforming the market. Academic research (Jegadeesh & Titman 1993) shows stocks with strong relative momentum tend to keep outperforming for 3–12 months. >+5% → BUY | <-5% → SELL | in between → NEUTRAL
Relative Strength vs SPY
Measures how this stock has performed relative to the S&P 500. Persistent outperformance signals institutional sponsorship and sector leadership. Underperformance warns of rotation out of the stock, even in a rising market.
5-year in-sample backtest of the combined MA/RSI/MACD signal
| Signal | # Signals | Hit Rate 5d | Hit Rate 10d | Hit Rate 20d | Avg Return 5d | Avg Return 10d | Avg Return 20d |
|---|---|---|---|---|---|---|---|
| BUY | 513 | 56.5% | 62.6% | 60.6% | +0.54% | +0.79% | +1.05% |
| SELL | 393 | 50.1% | 49.4% | 49.4% | +0.09% | +0.56% | +1.96% |
Hit rate = % of BUY signals where price was higher (or SELL signals where it was lower) at the given horizon. Does not account for transaction costs. In-sample only — not a prediction of future performance.
Last 20 trading days
| Date | Close | MA | RSI | MACD | Combined |
|---|---|---|---|---|---|
| 2026-10-26 | $451.63 | HOLD | HOLD | BUY | BUY |
| 2026-10-27 | $445.88 | HOLD | HOLD | BUY | BUY |
| 2026-10-28 | $444.18 |
| HOLD |
| HOLD |
| BUY |
| BUY |
| 2026-10-29 | $448.76 | HOLD | HOLD | BUY | BUY |
| 2026-10-30 | $432.01 | HOLD | HOLD | HOLD | BUY |
| 2026-11-02 | $436.87 | HOLD | HOLD | HOLD | BUY |
| 2026-11-03 | $440.75 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-04 | $482.10 | HOLD | HOLD | BUY | HOLD |
| 2026-11-05 | $468.52 | HOLD | HOLD | BUY | HOLD |
| 2026-11-06 | $452.80 | HOLD | HOLD | BUY | HOLD |
| 2026-11-09 | $460.56 | HOLD | HOLD | BUY | BUY |
| 2026-11-10 | $450.04 | HOLD | HOLD | HOLD | BUY |
| 2026-11-11 | $449.53 | HOLD | HOLD | HOLD | BUY |
| 2026-11-12 | $439.89 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-13 | $443.59 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-16 | $437.75 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-17 | $430.53 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-18 | $420.95 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-19 | $407.24 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-20 | $399.05 | HOLD | HOLD | SELL | HOLD |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Official website ↗